Author Archive: Jeremy Parkinson
Featured Stocks In December’s Dividend Growth Model Portfolio
This report highlights last month’s top performers and features a stock from the current portfolio. Recap from November’s Picks Our Dividend Growth Stocks Model Portfolio outperformed the S&P 500 in November. The Model Portfolio rose 2.0% on a price return basis and rose 2.3% on a total return basis. The S&P 500 rose 1.7% on […]
Time To Buy Gold For 2018 As The Run-Down Starts?
The price of gold could rally to $4,200 as the Federal Reserve tries, and fails to normalize monetary policy over the next few years according to analysts at CLSA. CLSA has long been a gold bull, advocating the yellow metal for its model portfolio since 2002. So far, this trade has yielded mixed results. After the price […]
Energy Is Still A Beast, While Financials Finally Woke Up
My Swing Trading Approach There are some nice swing trade setups to be had, but I am concerned about adding additional long positions to the portfolio today. Tightening the stops will be in order. Indicators VIX – Expected bounce yesterday, considering the previous day’s close at 9.15. May see a continued bounce again today. T2108 (% of […]
FV Bitcoin And Ripple Buy Sell Or Hold?
I have been talking about Bitcoin for a few weeks now and stated that there would be a rally back and that the bubble had not burst. Sure enough our technical analysis of the stock charts was accurate. Video length: 00:05:20
Here’s A Look At The Drug That Underpins The Latest Aptose Biosciences Inc. Designation
TM editors’ note: This article discusses a penny stock and/or microcap. Such stocks are easily manipulated; do your own careful due diligence. At the end of December, Aptose Biosciences Inc. (Nasdaq: APTO) announced that the Food and Drug Administration (FDA) in the US had granted Orphan Drug Designation to its lead development asset. The company […]
December Jobs Up 148K Following ADP 250K “Overheating” Estimate
Yesterday, Mark Zanzi feared the jobs market would overheat. ADP estimated 250,000 jobs in Dec. The BLS reports 148K. Initial Reaction Today’s establishment survey shows jobs rose by 148,000. The household survey (Table A) shows employment only rose by 104,000 while unemployment fell by 40,000. ADP estimated December Jobs at a whopping 250,000. Mark Zandi, chief economist […]
Yen & VIX Continue Lower
With US indices continuing to march ever higher, no surprise to see our Yen complex of pairs move strongly upwards, and bearish sentiment in the Yen index gather momentum. Of the pairs we track the commodity yen crosses have been particularly bullish, and reflecting further current risk off market sentiment, with cad/jpy also benefiting from […]
U.S. Dollar Checks, Bounces From Support On NFP Disappointment
Coming into this morning’s Non-Farm Payrolls report out of the United States – a glimmer of hope had developed for U.S. Dollar bulls as the Greenback continued to respect the support that was established earlier in the week. Prices had trickled up to the first resistance level we had looked at in yesterday’s article, but […]
Markit Services PMI: Business Activity Growth Softens In December
The December US Services Purchasing Managers’ Index conducted by Markit came in at 53.7 percent, down 0.8 from the final November estimate of 54.5. The Investing.com consensus was for 55.9 percent. Markit’s Services PMI is a diffusion index: A reading above 50 indicates expansion in the sector; below 50 indicates contraction. Here is the opening from the […]
Weak Services Report And Dovish Comments Weigh On The Dollar
After the disappointing Non-Farm Payrolls only temporarily hurt the US dollar, the greenback received two more blows. The ISM Non-Manufacturing PMI, which is usually a hint towards the NFP, was released 90 minutes afterward, and missed expectations: a fall from 57.4 to 55.9, below 57.6 that was expected. The employment component actually advanced and it proved to […]
